Zota Health Care Limited has submitted a Statement of Deviation and/or Variation in the utilization of proceeds from its preferential issue for the quarter ended December 31, 2024. The Audit Committee reviewed the statement, confirming that there are no deviations or variations noted in the usage of funds. The company raised ₹179.07 crore, with ₹84.34 crore received to date and the remaining ₹94.73 crore expected from warrant holders by February 13, 2026.
This update could positively influence investor sentiment, reflecting sound fund management and potential growth through project expansions and working capital enhancement. The lack of deviations indicates stability and may reassure investors regarding the company's financial governance.